IN Brief:
- Rothamsted field trials cut free asparagine by up to 93% in gene-edited wheat without reducing yield.
- Lower asparagine translated into sharply reduced acrylamide in baked and toasted products, including some bread samples below detectable limits.
- The work could shift acrylamide control further upstream, from process adjustment into raw-material design.
Rothamsted Research has developed gene-edited wheat lines that sharply reduce the precursor responsible for acrylamide formation, offering bakery and snacks manufacturers a potentially important new route to contaminant control.
The work focuses on free asparagine, the amino acid that converts into acrylamide during high-temperature cooking processes such as baking, frying, and toasting. In two years of field trials, Rothamsted researchers used CRISPR genome editing to cut free asparagine concentrations in wheat grain by 59% in one edited line and by up to 93% in a dual-edited line, all without reducing crop yield. That yield result is critical. Food manufacturers and millers have long known the contaminant problem, but upstream fixes have struggled when they introduced agronomic penalties.
The edits targeted the TaASN2 gene, which plays a central role in asparagine production, and in one case also partially knocked out the related TaASN1 gene. Rothamsted said the reduction in free asparagine carried through into finished products. Bread and biscuits made from the edited wheat showed substantially lower acrylamide formation, with some toasted bread samples falling below detectable limits. Conventional mutagenesis through TILLING also reduced free asparagine, but only by around 50%, and with a yield penalty of nearly 25%, which underlines the difference between broad mutation and targeted editing.
For processors, the significance lies in where the intervention happens. Acrylamide has usually been managed downstream through recipe changes, enzyme treatments, bake profiles, raw-material selection, and line controls. Those tools remain important, but they all operate after the crop has already arrived with a certain risk profile. Low-asparagine wheat changes the equation by reducing that risk at source. In practical terms, that could widen the operating window for bread, biscuits, crackers, breakfast cereals, and fried potato-adjacent formulations that use wheat ingredients, allowing safety targets to be met with less compromise on colour, flavour, and texture.
The timing is useful. Acrylamide controls have become a standing issue across European food manufacturing, particularly for baked and fried categories. Benchmark levels already shape process management, and the pressure to tighten compliance is not going away. That creates an awkward challenge for manufacturers. Pushing harder on browning control can affect consumer acceptance, while reformulation options are not equally suited to every product. A raw material that inherently generates less acrylamide could therefore be attractive not because it removes process control, but because it makes that control more reliable.
There is also a wider signal here about the direction of food-safety innovation. Much of the sector’s recent investment has centred on digital inspection, traceability, and line monitoring. Those remain essential, but ingredient and crop design are increasingly part of the same conversation. Safer food is not only about detecting problems on the line. In some cases, it is about engineering out part of the hazard before processing begins.
That makes this more than a wheat story. It is also a regulatory and supply-chain story, especially in the UK, where the post-Brexit precision-breeding framework has created more room for this kind of development. If low-asparagine wheat progresses beyond field trials and into commercial supply, millers, bakeries, biscuit producers, and snack manufacturers will all need to decide how much value they place on a lower-risk raw material and whether that value can be reflected in contracts or product specifications.
The route to market will not be immediate. Commercial adoption will depend on seed multiplication, regulatory handling, customer acceptance, and proof that the agronomic and functional performance holds up at scale. Even so, the direction is clear. Acrylamide mitigation has long been treated as a processing problem. Rothamsted’s work suggests it may increasingly become a crop-design opportunity as well.
